1/4 of people who took the mRNA therapies had unintentional proteins created within their cells, study says.
https://archive.is/V9QTA
I am hoping those proteins are harmless, the study claims theres "no evidence" of them being any way bad, but that doens't mean anything.
COVID-19 News and Discussions
Re: COVID-19 News and Discussions
To know is essentially the same as not knowing. The only thing that occurs is the rearrangement of atoms in your brain.
Re: COVID-19 News and Discussions
And, as always, bye bye.
Re: COVID-19 News and Discussions
Social Distancing Was More Effective at Preventing Local COVID-19 Transmission Than International Border Closures
December 14, 2023
Introduction:
December 14, 2023
Introduction:
Read more here: https://www.eurekalert.org/news-releases/1011299(Eurekalert) LA JOLLA, CA—Elucidating human contact networks could help predict and prevent the transmission of SARS-CoV-2 and future pandemic threats. A new study from Scripps Research scientists and collaborators points to which public health protocols worked to mitigate the spread of COVID-19—and which ones didn’t.
In the study, published online in Cell on December 14, 2023, the Scripps Research-led team of scientists investigated the efficacy of different mandates—including stay-at-home measures, social distancing and travel restrictions—at preventing local and regional transmission during different phases of the COVID-19 pandemic. They found that local transmission was driven by the amount of travel between locations, not by how geographically nearby they were. The study also revealed that the partial closure of the U.S.-Mexico border was ineffective at preventing cross-border transmission of the virus. These findings, in combination with ongoing genomic surveillance, could help guide public health policy to prevent future pandemics and mitigate the new “endemic” phase of COVID-19.
Don't mourn, organize.
-Joe Hill
-Joe Hill
Re: COVID-19 News and Discussions
COVID-19 v. Flu: A ‘much more serious threat,’ new study into long-term risks concludes
December 14, 2023 at 11:33 PM GMT
Almost from the start of SARS-CoV-2’s rampage around the globe, researchers and epidemiologists warned that it appeared to behave differently than known viruses, particularly seasonal flu. That included not only COVID-19’s general contagiousness compared to flu viruses, but also its ability to cause clotting problems in the veins and arteries, result in loss of smell and/or taste, and even lead to a rare multisystem inflammatory syndrome in children.
That message was taken more or less seriously, depending on geography and, often, politics. But as a new study makes clear, the warnings have proved darkly prophetic.
The study, a comparative analysis with 18 months of follow-up of hospital admissions for those with COVID-19 and those with seasonal flu, found that COVID-19 patients experienced significantly higher rates of death, healthcare utilization, and adverse health outcomes in most organ systems than did patients with the flu. Its results were published on Dec. 14 in the infectious diseases section of the medical journal The Lancet.
“This was evident in pre-Delta, Delta, and Omicron (strains), and evident in both vaccinated and unvaccinated individuals,” says Ziyad Al-Aly, the director of the Clinical Epidemiology Center, chief of research and development service at the Veterans Affairs Saint Louis Health Care System, and senior author of the study. “COVID remains a much more serious threat to human health than the flu.”
The study arrives as the U.S. is seeing a significant uptick in COVID-related hospitalizations and with 15 states reporting high or very high levels of respiratory illness, which takes in COVID-19, the flu, RSV, and other respiratory diseases. The hospitalization numbers are well below those posted during Omicron’s peak, but with colder weather moving more people indoors and into crowded settings, they may reasonably be expected to continue rising.
https://fortune.com/2023/12/14/covid-19 ... yn-barber/
December 14, 2023 at 11:33 PM GMT
Almost from the start of SARS-CoV-2’s rampage around the globe, researchers and epidemiologists warned that it appeared to behave differently than known viruses, particularly seasonal flu. That included not only COVID-19’s general contagiousness compared to flu viruses, but also its ability to cause clotting problems in the veins and arteries, result in loss of smell and/or taste, and even lead to a rare multisystem inflammatory syndrome in children.
That message was taken more or less seriously, depending on geography and, often, politics. But as a new study makes clear, the warnings have proved darkly prophetic.
The study, a comparative analysis with 18 months of follow-up of hospital admissions for those with COVID-19 and those with seasonal flu, found that COVID-19 patients experienced significantly higher rates of death, healthcare utilization, and adverse health outcomes in most organ systems than did patients with the flu. Its results were published on Dec. 14 in the infectious diseases section of the medical journal The Lancet.
“This was evident in pre-Delta, Delta, and Omicron (strains), and evident in both vaccinated and unvaccinated individuals,” says Ziyad Al-Aly, the director of the Clinical Epidemiology Center, chief of research and development service at the Veterans Affairs Saint Louis Health Care System, and senior author of the study. “COVID remains a much more serious threat to human health than the flu.”
The study arrives as the U.S. is seeing a significant uptick in COVID-related hospitalizations and with 15 states reporting high or very high levels of respiratory illness, which takes in COVID-19, the flu, RSV, and other respiratory diseases. The hospitalization numbers are well below those posted during Omicron’s peak, but with colder weather moving more people indoors and into crowded settings, they may reasonably be expected to continue rising.
https://fortune.com/2023/12/14/covid-19 ... yn-barber/
A vote for Trump, a third party candidate, or no vote at all, is a vote for a dystopian future.
Re: COVID-19 News and Discussions
Why Covid is still flooring some people
10 hours ago
What is it like to catch Covid now? It is a question I have been pondering since a friend was surprised by how roughed up they were by it. Their third bout of Covid was significantly worse than the previous time they caught it.
"I thought every time you catch an illness it's supposed to be a bit better each time?" was the message from his sickbed.
[...]
Antibody levels are relatively low because it has been a long time since many of us were vaccinated (if you are young and healthy you were only ever offered two doses and a booster) or infected, which also tops up immunity.
Prof Peter Openshaw, from Imperial College London, told me: "The thing that made the huge difference before was the very wide and fast rollout of vaccines - even young adults managed to get vaccinated, and that made an absolutely huge difference."
[...]
"I'm also hearing of people having nasty bouts of Covid, who are otherwise young and fit. It's a surprisingly devious virus, sometimes making people quite ill and occasionally leading to having 'long Covid'," he says.
https://www.bbc.co.uk/news/health-67726685
10 hours ago
What is it like to catch Covid now? It is a question I have been pondering since a friend was surprised by how roughed up they were by it. Their third bout of Covid was significantly worse than the previous time they caught it.
"I thought every time you catch an illness it's supposed to be a bit better each time?" was the message from his sickbed.
[...]
Antibody levels are relatively low because it has been a long time since many of us were vaccinated (if you are young and healthy you were only ever offered two doses and a booster) or infected, which also tops up immunity.
Prof Peter Openshaw, from Imperial College London, told me: "The thing that made the huge difference before was the very wide and fast rollout of vaccines - even young adults managed to get vaccinated, and that made an absolutely huge difference."
[...]
"I'm also hearing of people having nasty bouts of Covid, who are otherwise young and fit. It's a surprisingly devious virus, sometimes making people quite ill and occasionally leading to having 'long Covid'," he says.
https://www.bbc.co.uk/news/health-67726685
A vote for Trump, a third party candidate, or no vote at all, is a vote for a dystopian future.
Re: COVID-19 News and Discussions
A vote for Trump, a third party candidate, or no vote at all, is a vote for a dystopian future.
Re: COVID-19 News and Discussions
WHO designates JN.1 as separate COVID-19 variant of interest
December 19, 2023
Due to its rapid growth and potential to add to the respiratory virus burden in Northern Hemisphere countries, the World Health Organization (WHO) today designated JN.1, part of the BA.2.86 SARS-CoV-2 lineage, as its own variant of interest.
The announcement came following an assessment from the WHO's Technical Advisory Group on SARS-CoV-2 evolution.
JN.1, first detected on August 25, contains L455S mutation in the spike protein, compared to the parent BA.2.86 variant. The mutation is thought to enhance JN.1's immune-evasion capabilities. The WHO had first designated BA.2.86 as a variant under monitoring in August, then in late November upgraded it and its offshoots, including JN.1, as a variant of interest.
Over the past month, the proportion of JN.1 viruses has rapidly increased, rising from 3.3% in early November to 27.1% by early December. Countries reporting the highest proportions include France, the United States, Singapore, Canada, and the United Kingdom.
The WHO said its Western Pacific region saw the biggest jump in JN.1 proportions. Singapore is experiencing a record surge in COVID-19, which prompted a health ministry statement strongly urging people to wear a mask, according to a media report.
https://www.cidrap.umn.edu/covid-19/who ... t-interest
PAHO/Flickr cc
December 19, 2023
Due to its rapid growth and potential to add to the respiratory virus burden in Northern Hemisphere countries, the World Health Organization (WHO) today designated JN.1, part of the BA.2.86 SARS-CoV-2 lineage, as its own variant of interest.
The announcement came following an assessment from the WHO's Technical Advisory Group on SARS-CoV-2 evolution.
JN.1, first detected on August 25, contains L455S mutation in the spike protein, compared to the parent BA.2.86 variant. The mutation is thought to enhance JN.1's immune-evasion capabilities. The WHO had first designated BA.2.86 as a variant under monitoring in August, then in late November upgraded it and its offshoots, including JN.1, as a variant of interest.
Over the past month, the proportion of JN.1 viruses has rapidly increased, rising from 3.3% in early November to 27.1% by early December. Countries reporting the highest proportions include France, the United States, Singapore, Canada, and the United Kingdom.
The WHO said its Western Pacific region saw the biggest jump in JN.1 proportions. Singapore is experiencing a record surge in COVID-19, which prompted a health ministry statement strongly urging people to wear a mask, according to a media report.
https://www.cidrap.umn.edu/covid-19/who ... t-interest
PAHO/Flickr cc
A vote for Trump, a third party candidate, or no vote at all, is a vote for a dystopian future.
Re: COVID-19 News and Discussions
Inhaled COVID vaccines stop infection in its tracks in monkey trials
New results hint at how to perfect ‘mucosal’ vaccines, which are delivered up the nose or down the throat.
19 December 2023
Delivery of COVID vaccines directly to the lungs and nose can stop SARS-CoV-2 infections in their tracks, according to a trio of new studies in monkeys. The research offers a boost to the wave of ‘mucosal’ COVID-19 vaccines now in development — and provides clues about how they might be improved.
Until now, there has been little evidence that mucosal vaccines, which are taken by nose or mouth, shield people against infection any better than existing COVID-19 jabs do. Even so, some countries have already approved such vaccines, and key trials are under way in the United States, with others set to start.
Together, the studies show that how and where vaccines are delivered can have a profound effect on the immunity generated and the protection conferred. The latest results also raise hopes that mucosal vaccines that offer ‘sterilising’ immunity — complete blockage of infection — could become a reality.
“These studies are showing you can get near sterilising immunity,” says Akiko Iwasaki, an immunologist at the Yale School of Medicine in New Haven, Connecticut. "It’s not complete science fiction to think about developing vaccines that would stop transmission and infection."
https://www.nature.com/articles/d41586-023-04003-4
Particles of SARS-CoV-2 (yellow; artificially coloured) infect cells in the lining of the nasal passage.
Credit: National Institute of Allergy and Infectious Diseases/National Institutes of Health/SPL
New results hint at how to perfect ‘mucosal’ vaccines, which are delivered up the nose or down the throat.
19 December 2023
Delivery of COVID vaccines directly to the lungs and nose can stop SARS-CoV-2 infections in their tracks, according to a trio of new studies in monkeys. The research offers a boost to the wave of ‘mucosal’ COVID-19 vaccines now in development — and provides clues about how they might be improved.
Until now, there has been little evidence that mucosal vaccines, which are taken by nose or mouth, shield people against infection any better than existing COVID-19 jabs do. Even so, some countries have already approved such vaccines, and key trials are under way in the United States, with others set to start.
Together, the studies show that how and where vaccines are delivered can have a profound effect on the immunity generated and the protection conferred. The latest results also raise hopes that mucosal vaccines that offer ‘sterilising’ immunity — complete blockage of infection — could become a reality.
“These studies are showing you can get near sterilising immunity,” says Akiko Iwasaki, an immunologist at the Yale School of Medicine in New Haven, Connecticut. "It’s not complete science fiction to think about developing vaccines that would stop transmission and infection."
https://www.nature.com/articles/d41586-023-04003-4
Particles of SARS-CoV-2 (yellow; artificially coloured) infect cells in the lining of the nasal passage.
Credit: National Institute of Allergy and Infectious Diseases/National Institutes of Health/SPL
A vote for Trump, a third party candidate, or no vote at all, is a vote for a dystopian future.
Re: COVID-19 News and Discussions
To know is essentially the same as not knowing. The only thing that occurs is the rearrangement of atoms in your brain.
Re: COVID-19 News and Discussions
Unexpected New COVID Symptoms Arise as JN.1 Variant Continues to Spread
Tom Hale
December 29, 2023
Introduction:
Tom Hale
December 29, 2023
Introduction:
Read more here: https://www.iflscience.com/unexpected- ... ead-72224(IFL Science) With cases of COVID reaching relatively high levels once again, here are the symptoms to keep an eye out for.
The JN.1 COVID variant had a rapid spread throughout December 2023 and has now become the most common strain of the virus spreading across the US, according to the US Centers for Disease Control and Prevention (CDC). Cases of JN.1 are also creeping up in the UK, as well as China and India.
Health authorities currently aren’t sure whether JN.1 infections produce different symptoms from other variants, with the CDC noting that “the types of symptoms and how severe they are usually depend more on a person’s immunity and overall health rather than which variant causes the infection.”
That said, there is some decent evidence that people are reporting slightly different COVID symptoms this season.
The latest data from December 2023 by the UK’s Office for National Statistics suggests the most commonly reported symptoms among surveyed respondents with COVID-19 include:
• Runny nose (31.1 percent)
• Cough (22.9 percent)
• Headache (20.1 percent)
• Weakness or tiredness (19.6 percent)
• Muscle ache (15.8 percent)
• Sore throat (13.2 percent)
• Trouble sleeping (10.8 percent)
• Worry or anxiety (10.5 percent).
Don't mourn, organize.
-Joe Hill
-Joe Hill
